US0008991046
US0008991046
ADMA Biologics Inc
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 100/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±59.1% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.7x).
Beta (Market Relation)
0.69x
DefensiveVolatility (5Y p.a.)
59.1% p.a.
5-Year HorizonMax Drawdown (5Y)
-69.0%
5-Year HorizonSharpe Ratio
0.90
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -29.3% |
| 3 Years | 57.3% | -69.0% | 0.75 | +45.7% |
| 5 Years | 59.1% | -69.0% | 0.9 | +55.9% |
| 10 Years | 68.4% | -84.1% | 0.03 | +4.4% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (59.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -84.1% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
6 ISS Score: 6 / 10
Audit Risk
8 ISS Score: 8 / 10
Board Risk
5 ISS Score: 5 / 10
Short Ratio
12.18